A multi-center distributed learning approach for Parkinson's disease classification using the traveling model paradigm

Front Artif Intell. 2024 Feb 7:7:1301997. doi: 10.3389/frai.2024.1301997. eCollection 2024.

Abstract

Distributed learning is a promising alternative to central learning for machine learning (ML) model training, overcoming data-sharing problems in healthcare. Previous studies exploring federated learning (FL) or the traveling model (TM) setup for medical image-based disease classification often relied on large databases with a limited number of centers or simulated artificial centers, raising doubts about real-world applicability. This study develops and evaluates a convolution neural network (CNN) for Parkinson's disease classification using data acquired by 83 diverse real centers around the world, mostly contributing small training samples. Our approach specifically makes use of the TM setup, which has proven effective in scenarios with limited data availability but has never been used for image-based disease classification. Our findings reveal that TM is effective for training CNN models, even in complex real-world scenarios with variable data distributions. After sufficient training cycles, the TM-trained CNN matches or slightly surpasses the performance of the centrally trained counterpart (AUROC of 83% vs. 80%). Our study highlights, for the first time, the effectiveness of TM in 3D medical image classification, especially in scenarios with limited training samples and heterogeneous distributed data. These insights are relevant for situations where ML models are supposed to be trained using data from small or remote medical centers, and rare diseases with sparse cases. The simplicity of this approach enables a broad application to many deep learning tasks, enhancing its clinical utility across various contexts and medical facilities.

Keywords: Parkinson's disease; distributed learning; federated learning; multi-center; traveling model.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Parkinson's Association of Alberta, the Hotchkiss Brain Institute, the Canadian Consortium on Neurodegeneration in Aging (CCNA), the Canadian Open Neuroscience Platform (CONP), the Natural Sciences and Engineering Research Council of Canada (NSERC), the Discovery Grant, the Canada Research Chairs program, the River Fund at Calgary Foundation, the Canadian Institutes for Health Research, the Tourmaline Chair in Parkinson's disease, and the Institut de valorisation des données (IVADO).